Evidence map›Paper›PMID 33468484›Full record

ArticleAntimicrobial agents and chemotherapy2021

Hervé Poilvache, Albert Ruiz-Sorribas, Olivier Cornu, Françoise Van Bambeke

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. TargetingBiofilm · 2025
    Article
  5. Pathogens (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Development of an innovativeFrontiers in medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hervé PoilvacheUniversité catholique de Louvain, Institut de Recherche Expérimentale et Clinique, Neuromusculoskeletal Laboratory, Brussels, Belgium.ORCID 0000-0001-8859-578X
Albert Ruiz-SorribasUniversité catholique de Louvain, Louvain Drug Research Institute, Pharmacologie cellulaire et moléculaire, Brussels, Belgium.
Olivier CornuUniversité catholique de Louvain, Institut de Recherche Expérimentale et Clinique, Neuromusculoskeletal Laboratory, Brussels, Belgium.
Françoise Van BambekeUniversité catholique de Louvain, Louvain Drug Research Institute, Pharmacologie cellulaire et moléculaire, Brussels, Belgium francoise.vanbambeke@uclouvain.be.ORCID 0000-0002-0052-7991
Cliniques Universitaires Saint-Luc · BEUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prosthetic joint infections (PJI) are frequent complications of arthroplasties. Their treatment is made complex by the rapid formation of bacterial biofilms, limiting the effectiveness of antibiotic therapy. In this study, we explore the effect of a tri-enzymatic cocktail (TEC) consisting of an endo-1,4-β-d-glucanase, a β-1,6-hexosaminidase, and an RNA/DNA nonspecific endonuclease combined with antibiotics of different classes against biofilms of

Indexed as

Anti-Bacterial AgentsStaphylococcal InfectionsAnimalsBiofilmsEscherichia coliMiceStaphylococcus aureusStaphylococcus epidermidisAnti-Bacterial Agentsantibioticsbiofilmscellulasecoagulase-negative staphylococcidispersin BendonucleaseenzymesEscherichia coliprosthesis infectionsprosthetic joint infectionStaphylococcus aureusStaphylococcus epidermidis

Identifiers

PMID33468484
PMCPMC8097427
OpenAlexW3123973074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.